Trials / Completed
CompletedNCT01176201
14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
An Open-Label Study to Determine ADME of 14C Labeled SLV337 After a Single Dose of an Oral Suspension
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Abbott Products · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label study to determine the ADME (Absorption, Disposition, Metabolism and Excretion) of 14C labeled SLV337 after a single dose of an oral suspension.
Detailed description
The Absorption, Disposition, Metabolism and Excretion of SLV337 will be investigated after a single dose of an oral suspension of 14C-SLV337.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SLV337 suspension | 400 mg experimental |
| DRUG | SLV337 capsule | 5 x 200 mg immediate release capsule |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-08-05
- Last updated
- 2011-08-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01176201. Inclusion in this directory is not an endorsement.